Arena Pharmaceuticals Inc Ret. on assets
What is the Ret. on assets of Arena Pharmaceuticals Inc?
The Ret. on assets of Arena Pharmaceuticals Inc is -34.53%
What is the definition of Ret. on assets?
Return on assets indicates how profitable a company’s assets are in generating revenue. It is computed by dividing net income by average total assets.
ttm (trailing twelve months)
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Ret. on assets of companies in the Health Care sector on NASDAQ compared to Arena Pharmaceuticals Inc
What does Arena Pharmaceuticals Inc do?
Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas
Companies with ret. on assets similar to Arena Pharmaceuticals Inc
- Osirium Technologies PLC has Ret. on assets of -34.63%
- Spinal Elements has Ret. on assets of -34.59%
- Charah Solutions Inc has Ret. on assets of -34.58%
- New Target Mining has Ret. on assets of -34.58%
- Canoe Mining Ventures has Ret. on assets of -34.57%
- Nelson Resources has Ret. on assets of -34.54%
- Arena Pharmaceuticals Inc has Ret. on assets of -34.53%
- Mogo Inc has Ret. on assets of -34.50%
- Lysogene SA has Ret. on assets of -34.50%
- NuCana plc has Ret. on assets of -34.48%
- Dowway has Ret. on assets of -34.47%
- Neoleukin Therapeutics has Ret. on assets of -34.43%
- ASA Gold and Precious Metals Ltd has Ret. on assets of -34.43%